Share

[Application of impulse complex modulated electromagnetic fields in management of patients with diabetic polyneuropathy].

A V Musaev, S G Guseĭnova, S S Imamverdieva

PAPERpubmedZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2002OtherEffect: benefitEvidence: Insufficient

Abstract

One hundred and twenty-one patients with diabetic polyneuropathy (DP) underwent a clinical and electroneuromyographic investigation before and after treatment with impulse complex modulated electromagnetic fields (ICM EMF) of varying frequency (100 and 10 Hz). Based on TSS and NIS LL scale tests, a correlation between the progression and occurrence of the basic subjective and objective signs of the disease and a DP stage was revealed. The alterations of segmental and peripheral neuromotor system manifesting in reduction of muscular bioelectrical activity, impulse conduction velocities in efferent fibers of peripheral nerves and maximal M-response amplitude were found to be related to DP stage and diabetes mellitus duration. A decrease of H-reflex amplitude and Hmax/Mmax ratio measured in crural muscles proved to be the earliest and most significant electroneuromyographic DP trait. ICM EMF application promotes a regression of DP basic clinical symptoms, an improvement of conduction function of peripheral nerves and 1a afferents state as well as a reflex excitability of functionally different spinal motoneurons. Therapeutic efficacy of a 10 Hz ICM EMF, particularly for DP primary stages and diabetes mellitus up to 10-year duration, was proved.

AI evidence extraction

At a glance
Study type
Other
Effect direction
benefit
Population
Patients with diabetic polyneuropathy
Sample size
121
Exposure
therapeutic electromagnetic field device (impulse complex modulated EMF)
Evidence strength
Insufficient
Confidence: 66% · Peer-reviewed: yes

Main findings

In 121 patients with diabetic polyneuropathy assessed before and after treatment, application of impulse complex modulated electromagnetic fields (100 Hz and 10 Hz) was reported to promote regression of basic clinical symptoms and improvement in several electroneuromyographic measures (including conduction function of peripheral nerves and reflex-related measures). The abstract states therapeutic efficacy was shown for 10 Hz exposure, particularly in early-stage diabetic polyneuropathy and diabetes duration up to 10 years.

Outcomes measured

  • Clinical symptoms of diabetic polyneuropathy
  • TSS score
  • NIS LL score
  • Electroneuromyographic measures (muscular bioelectrical activity
  • impulse conduction velocities in efferent fibers of peripheral nerves
  • maximal M-response amplitude)
  • H-reflex amplitude
  • Hmax/Mmax ratio
  • Conduction function of peripheral nerves
  • State of Ia afferents
  • Reflex excitability of spinal motoneurons

Limitations

  • No control or comparison group described in the abstract
  • Randomization/blinding not described
  • Exposure parameters beyond frequency (e.g.
  • intensity
  • duration
  • dosing) not reported
  • Follow-up duration not reported
View raw extracted JSON
{
  "study_type": "other",
  "exposure": {
    "band": null,
    "source": "therapeutic electromagnetic field device (impulse complex modulated EMF)",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": null
  },
  "population": "Patients with diabetic polyneuropathy",
  "sample_size": 121,
  "outcomes": [
    "Clinical symptoms of diabetic polyneuropathy",
    "TSS score",
    "NIS LL score",
    "Electroneuromyographic measures (muscular bioelectrical activity, impulse conduction velocities in efferent fibers of peripheral nerves, maximal M-response amplitude)",
    "H-reflex amplitude",
    "Hmax/Mmax ratio",
    "Conduction function of peripheral nerves",
    "State of Ia afferents",
    "Reflex excitability of spinal motoneurons"
  ],
  "main_findings": "In 121 patients with diabetic polyneuropathy assessed before and after treatment, application of impulse complex modulated electromagnetic fields (100 Hz and 10 Hz) was reported to promote regression of basic clinical symptoms and improvement in several electroneuromyographic measures (including conduction function of peripheral nerves and reflex-related measures). The abstract states therapeutic efficacy was shown for 10 Hz exposure, particularly in early-stage diabetic polyneuropathy and diabetes duration up to 10 years.",
  "effect_direction": "benefit",
  "limitations": [
    "No control or comparison group described in the abstract",
    "Randomization/blinding not described",
    "Exposure parameters beyond frequency (e.g., intensity, duration, dosing) not reported",
    "Follow-up duration not reported"
  ],
  "evidence_strength": "insufficient",
  "confidence": 0.66,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "diabetic polyneuropathy",
    "impulse complex modulated electromagnetic fields",
    "ICM EMF",
    "10 Hz",
    "100 Hz",
    "electroneuromyography",
    "H-reflex",
    "nerve conduction",
    "TSS",
    "NIS LL"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 5286

[Application of impulse complex modulated electromagnetic fields in management of patients with diabetic polyneuropathy]. · Non-native EMF